<?xml version="1.0" encoding="UTF-8"?>
<ref id="B126-biomedicines-08-00060">
 <label>126.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cavazzana-Calvo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hacein-Bey</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>De Saint Basile</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Gross</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Yvon</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Nusbaum</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Selz</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Hue</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Certain</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Casanova</surname>
    <given-names>J.-L.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease</article-title>
  <source>Science</source>
  <year>2000</year>
  <volume>288</volume>
  <fpage>669</fpage>
  <lpage>672</lpage>
  <pub-id pub-id-type="doi">10.1126/science.288.5466.669</pub-id>
  <pub-id pub-id-type="pmid">10784449</pub-id>
 </element-citation>
</ref>
